114 related articles for article (PubMed ID: 31540771)
1. miR-182 contributes to cell adhesion-mediated drug resistance in multiple myeloma via targeting PDCD4.
Wu Y; Zhu X; Shen R; Huang J; Xu X; He S
Pathol Res Pract; 2019 Nov; 215(11):152603. PubMed ID: 31540771
[TBL] [Abstract][Full Text] [Related]
2. miR-208a-3p suppresses cell apoptosis by targeting PDCD4 in gastric cancer.
Yin K; Liu M; Zhang M; Wang F; Fen M; Liu Z; Yuan Y; Gao S; Yang L; Zhang W; Zhang J; Guo B; Xu J; Liang H; Chen X; Guan W
Oncotarget; 2016 Oct; 7(41):67321-67332. PubMed ID: 27634902
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer.
Chen Z; Yuan YC; Wang Y; Liu Z; Chan HJ; Chen S
Breast Cancer Res Treat; 2015 Jul; 152(1):29-39. PubMed ID: 26026468
[TBL] [Abstract][Full Text] [Related]
4. Integrative analysis of differential miRNA and functional study of miR-21 by seed-targeting inhibition in multiple myeloma cells in response to berberine.
Luo X; Gu J; Zhu R; Feng M; Zhu X; Li Y; Fei J
BMC Syst Biol; 2014 Jul; 8():82. PubMed ID: 25000828
[TBL] [Abstract][Full Text] [Related]
5. miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.
Wei C; Song H; Sun X; Li D; Song J; Hua K; Fang L
Oncol Rep; 2015 Jul; 34(1):211-20. PubMed ID: 26063221
[TBL] [Abstract][Full Text] [Related]
6. Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia.
Yamanaka Y; Tagawa H; Takahashi N; Watanabe A; Guo YM; Iwamoto K; Yamashita J; Saitoh H; Kameoka Y; Shimizu N; Ichinohasama R; Sawada K
Blood; 2009 Oct; 114(15):3265-75. PubMed ID: 19641183
[TBL] [Abstract][Full Text] [Related]
7. Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma.
Zhao JJ; Chu ZB; Hu Y; Lin J; Wang Z; Jiang M; Chen M; Wang X; Kang Y; Zhou Y; Ni Chonghaile T; Johncilla ME; Tai YT; Cheng JQ; Letai A; Munshi NC; Anderson KC; Carrasco RD
Cancer Res; 2015 Oct; 75(20):4384-4397. PubMed ID: 26249174
[TBL] [Abstract][Full Text] [Related]
8. The PDCD4/miR-21 pathway in medullary thyroid carcinoma.
Pennelli G; Galuppini F; Barollo S; Cavedon E; Bertazza L; Fassan M; Guzzardo V; Pelizzo MR; Rugge M; Mian C
Hum Pathol; 2015 Jan; 46(1):50-7. PubMed ID: 25316501
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the tumour suppressor PDCD4 by miR-499 and miR-21 in oropharyngeal cancers.
Zhang X; Gee H; Rose B; Lee CS; Clark J; Elliott M; Gamble JR; Cairns MJ; Harris A; Khoury S; Tran N
BMC Cancer; 2016 Feb; 16():86. PubMed ID: 26867589
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA (miRNA)-to-miRNA Regulation of Programmed Cell Death 4 (PDCD4).
Ajuyah P; Hill M; Ahadi A; Lu J; Hutvagner G; Tran N
Mol Cell Biol; 2019 Sep; 39(18):. PubMed ID: 31235478
[TBL] [Abstract][Full Text] [Related]
11. Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells.
Abdi J; Rastgoo N; Chen Y; Chen GA; Chang H
BMC Cancer; 2019 Oct; 19(1):975. PubMed ID: 31638931
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-19a functions as an oncogene by regulating PTEN/AKT/pAKT pathway in myeloma.
Zhang X; Chen Y; Zhao P; Zang L; Zhang Z; Wang X
Leuk Lymphoma; 2017 Apr; 58(4):932-940. PubMed ID: 27830963
[TBL] [Abstract][Full Text] [Related]
13. EphA4 promotes cell proliferation and cell adhesion-mediated drug resistance via the AKT pathway in multiple myeloma.
Ding L; Shen Y; Ni J; Ou Y; Ou Y; Liu H
Tumour Biol; 2017 Mar; 39(3):1010428317694298. PubMed ID: 28351297
[TBL] [Abstract][Full Text] [Related]
14. HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma.
Qiu X; Dong S; Qiao F; Lu S; Song Y; Lao Y; Li Y; Zeng T; Hu J; Zhang L; Zhang L; Fan H
Oncogene; 2013 Jul; 32(27):3296-305. PubMed ID: 23604124
[TBL] [Abstract][Full Text] [Related]
15. Cell adhesion down-regulates the expression of vacuolar protein sorting 4B (VPS4B) and contributes to drug resistance in multiple myeloma cells.
Tang J; Ji L; Wang Y; Huang Y; Yin H; He Y; Liu J; Miao X; Wu Y; Xu X; He S; Cheng C
Int J Hematol; 2015 Jul; 102(1):25-34. PubMed ID: 25804841
[TBL] [Abstract][Full Text] [Related]
16. Study on the Association Between miRNA-202 Expression and Drug Sensitivity in Multiple Myeloma Cells.
Shen X; Guo Y; Qi J; Shi W; Wu X; Ni H; Ju S
Pathol Oncol Res; 2016 Jul; 22(3):531-9. PubMed ID: 26689580
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of miR-21 and PDCD4 in patients with stage II esophageal carcinoma after surgical resection.
Zhang J; Ma L; Shi D; Zhang Z; Yao C; Zhao X; Xu Q; Wen P; He L
J Cell Biochem; 2018 Jun; 119(6):4783-4791. PubMed ID: 29331036
[TBL] [Abstract][Full Text] [Related]
18. miR-374a-CCND1-pPI3K/AKT-c-JUN feedback loop modulated by PDCD4 suppresses cell growth, metastasis, and sensitizes nasopharyngeal carcinoma to cisplatin.
Zhen Y; Fang W; Zhao M; Luo R; Liu Y; Fu Q; Chen Y; Cheng C; Zhang Y; Liu Z
Oncogene; 2017 Jan; 36(2):275-285. PubMed ID: 27270423
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-21 stimulates gastric cancer growth and invasion by inhibiting the tumor suppressor effects of programmed cell death protein 4 and phosphatase and tensin homolog.
Li L; Zhou L; Li Y; Lin S; Tomuleasa C
J BUON; 2014; 19(1):228-36. PubMed ID: 24659669
[TBL] [Abstract][Full Text] [Related]
20. Cell adhesion induces overexpression of chromodomain helicase/ATPase DNA binding protein 1-like gene (CHD1L) and contributes to cell adhesion-mediated drug resistance (CAM-DR) in multiple myeloma cells.
Xu X; He Y; Miao X; Wu Y; Han J; Wang Q; Liu J; Zhong F; Ou Y; Wang Y; He S
Leuk Res; 2016 Aug; 47():54-62. PubMed ID: 27258734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
